These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1402141)

  • 41. Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.
    Urtasun R; Feldstein ML; Partington J; Tanasichuk H; Miller JD; Russell DB; Agboola O; Mielke B
    Br J Cancer; 1982 Jul; 46(1):101-8. PubMed ID: 6285947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of additive heat effect in the therapeutic gain factor in combined hyperthermia and radiotherapy: murine tumor response and foot reaction.
    Sougawa M; Urano M
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1561-8. PubMed ID: 1938566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
    Hofer KG; Lakkis M; Hofer MG
    Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing the chemosensitization of melphalan by misonidazole.
    Randhawa VS; Stewart FA; Denekamp J; Stratford MR
    Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ; de Ronde J; Hinchliffe M
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
    Wondergem J; Haveman J; van der Schueren E; van den Hoeven H; Breur K
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic effect of 1,3 bis (2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis and tumour response.
    Urano M; Majima H; Miller R; Kahn J
    Int J Hyperthermia; 1991; 7(3):499-510. PubMed ID: 1919145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour.
    Honess DJ; Hu DE; Bleehen NM
    Int J Hyperthermia; 1991; 7(4):667-79. PubMed ID: 1919161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
    Skov KA; Adomat H; Chaplin DJ; Farrell NP
    Anticancer Drug Des; 1990 Feb; 5(1):121-8. PubMed ID: 2156514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1981 Jan; 43(1):93-9. PubMed ID: 7459244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The radiosensitizing effects of misonidazole (MISO) in combination with diethyl maleate (DEM) in mouse mammary tumors.
    Ono K; Komuro C; Nishidai T; Shibamoto Y; Dodo Y; Takahashi M; Abe M; Shrieve DC
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1843-7. PubMed ID: 3759535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
    Hill SA; Bauer KD; Keng PC; Siemann DW
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.
    Griffin RJ; Okajima K; Ogawa A; Song CW
    Int J Radiat Biol; 1999 Oct; 75(10):1299-306. PubMed ID: 10549607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of the thermal response of murine tumour and normal tissues by a streptococcal preparation, OK-432 (Picibanil).
    Urano M; Taradi M; Taradi SK
    Int J Hyperthermia; 1991; 7(1):113-23. PubMed ID: 2051067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA
    Int J Hyperthermia; 1991; 7(6):893-903. PubMed ID: 1806643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
    Martin WM; McNally NJ; De Ronde J
    Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between adriamycin cytotoxicity and hyperthermia: growth-phase-dependent thermal sensitization.
    Urano M; Begley J; Reynolds R
    Int J Hyperthermia; 1994; 10(6):817-26. PubMed ID: 7884241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.